The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma

• D. Zakria,
• J. Burshtein,
• M. Shah,
• J. Siegel,
• S. Morgan-Linnell,
• B. Martin,
• R. Cook

Affiliations

D. Zakria

Icahn School of Medicine, Department of Dermatology, New York, United States of America

J. Burshtein

Icahn School of Medicine, Department of Dermatology, New York, United States of America

M. Shah

Icahn School of Medicine, Department of Dermatology, New York, United States of America

J. Siegel

Castle Biosciences, Inc., Friendswood, United States of America

S. Morgan-Linnell

Castle Biosciences, Inc., Friendswood, United States of America

B. Martin

Castle Biosciences, Inc., Friendswood, United States of America

R. Cook

Castle Biosciences, Inc., Friendswood, United States of America